1
Kuiper, J.L., Hashemi, S.M.S., Thunnissen, E., Snijders, P.J.F., Grünberg, K., Bloemena, E., Sie, D., Postmus, P.E., Heideman, D.A.M., Smit, E.F.
Veröffentlicht in: Kuiper , J L , Hashemi , S M S , Thunnissen , E , Snijders , P J F , Grünberg , K , Bloemena , E , Sie , D , Postmus , P E , Heideman , D A M & Smit , E F 2016 , ' Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment ' , The British journal of cancer , vol. 115 , no. 12 , pp. 1504-1512 . https://doi.org/10.1038/bjc.2016.372;
2016
Veröffentlicht in: Kuiper , J L , Hashemi , S M S , Thunnissen , E , Snijders , P J F , Grünberg , K , Bloemena , E , Sie , D , Postmus , P E , Heideman , D A M & Smit , E F 2016 , ' Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment ' , The British journal of cancer , vol. 115 , no. 12 , pp. 1504-1512 . https://doi.org/10.1038/bjc.2016.372;
2016
2
Koopman, B., Groen, H.J.M., Ligtenberg, M.J.L., Grunberg, K., Monkhorst, K., de Langen, A.J., Boelens, M.C., Paats, M.S., von der Thusen, J.H., Dinjens, W.N.M., Solleveld, N., van Wezel, T., Gelderblom, H., Hendriks, L.E., Speel, E.J.M., Theunissen, T.E., Kroeze, L.I., Mehra, N., Piet, B., van der Wekken, A.J., ter Elst, A., Timens, W., Willems, S.M., Meijers, R.W.J., de Leng, W.W.J., van Lindert, A.S.R., Radonic, T., Hashemi, S.M.S., Heideman, D.A.M., Schuuring, E., van Kempen, L.C.
Veröffentlicht in: Koopman , B , Groen , H J M , Ligtenberg , M J L , Grunberg , K , Monkhorst , K , de Langen , A J , Boelens , M C , Paats , M S , von der Thusen , J H , Dinjens , W N M , Solleveld , N , van Wezel , T , Gelderblom , H , Hendriks , L E , Speel , E J M , Theunissen , T E , Kroeze , L I , Mehra , N , Piet , B , van der Wekken , A J , ter Elst , A , Timens , W , Willems , S M , Meijers , R W J , de Leng , W W J , van Lindert , A S R , Radonic , T , Hashemi , S M S , Heideman , D A M , Schuuring , E & van Kempen , L C 2021 , ' Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations ' , Oncologist , vol. 26 , no. 8 , pp. E1347-E1358 . https://doi.org/10.1002/onco.13580;
2021
Veröffentlicht in: Koopman , B , Groen , H J M , Ligtenberg , M J L , Grunberg , K , Monkhorst , K , de Langen , A J , Boelens , M C , Paats , M S , von der Thusen , J H , Dinjens , W N M , Solleveld , N , van Wezel , T , Gelderblom , H , Hendriks , L E , Speel , E J M , Theunissen , T E , Kroeze , L I , Mehra , N , Piet , B , van der Wekken , A J , ter Elst , A , Timens , W , Willems , S M , Meijers , R W J , de Leng , W W J , van Lindert , A S R , Radonic , T , Hashemi , S M S , Heideman , D A M , Schuuring , E & van Kempen , L C 2021 , ' Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations ' , Oncologist , vol. 26 , no. 8 , pp. E1347-E1358 . https://doi.org/10.1002/onco.13580;
2021